PT  - JOURNAL ARTICLE
AU  - Yamamoto, Noboru
AU  - Kitano, Shigehisa
AU  - Koyama, Takafumi
AU  - Ikeda, Masafumi
AU  - Mizugaki, Hidenori
AU  - Narikiyo, Takatsugu
AU  - Yamaguchi, Yuki
AU  - Ishida, Takaaki
AU  - Takubo, Ryoko
AU  - Ogami, Chika
AU  - Sekiya, Mayuko
AU  - Nakagawa, Yuki
AU  - Kuboki, Yasutoshi
TI  - Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers
AID  - 10.1136/jitc-2024-009262
DP  - 2024 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e009262
VI  - 12
IP  - 7
4099  - http://jitc.bmj.com/content/12/7/e009262.short
4100  - http://jitc.bmj.com/content/12/7/e009262.full
SO  - J Immunother Cancer2024 Jul 01; 12
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.